Stockscreener 앱 받기
19.46
2.60%
-0.54
전일 마감가:
$20.00
열려 있는:
$19.34
하루 거래량:
440.92K
Relative Volume:
0.86
시가총액:
$1.15B
수익:
-
순이익/손실:
$-85.21M
주가수익비율:
-10.30
EPS:
-1.89
순현금흐름:
$-68.53M
1주 성능:
-9.61%
1개월 성능:
-0.66%
6개월 성능:
-5.02%
1년 성능:
-29.55%
1일 변동 폭
$19.25
$20.23
1주일 범위
$18.33
$24.64
52주 변동 폭
$13.30
$29.79
Enliven Therapeutics Inc Stock (ELVN) Company Profile
명칭
Enliven Therapeutics Inc
전화
720-647-8519
주소
6200 LOOKOUT ROAD, BOULDER
ELVN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELVN
Enliven Therapeutics Inc
|
19.47 | 1.18B | 0 | -85.21M | -68.53M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.28 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
631.38 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
425.69 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.92 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-16 | 개시 | Goldman | Buy |
| 2024-12-13 | 개시 | BTIG Research | Buy |
| 2024-09-09 | 개시 | H.C. Wainwright | Buy |
| 2024-06-11 | 개시 | Robert W. Baird | Outperform |
| 2024-04-09 | 개시 | Mizuho | Buy |
| 2023-03-29 | 개시 | Jefferies | Buy |
모두보기
Enliven Therapeutics Inc 주식(ELVN)의 최신 뉴스
Enliven Therapeutics Inc. stock daily chart insights2025 Bull vs Bear & Daily Market Momentum Tracking - newser.com
What analyst consensus says on Enliven Therapeutics Inc. stock2025 AllTime Highs & Weekly High Return Opportunities - newser.com
Enliven Therapeutics showcases promising results for ELVN-001 in CML trial - Traders Union
Enliven (NASDAQ: ELVN) presents ELVN-001 CML data at ASH 2025 with >1 log transcript declines - Stock Titan
Is Enliven Therapeutics Inc. stock positioned well for digital economyJuly 2025 PreEarnings & Fast Entry High Yield Tips - newser.com
Real time breakdown of Enliven Therapeutics Inc. stock performanceJuly 2025 Fed Impact & Free Long-Term Investment Growth Plans - newser.com
Can Enliven Therapeutics Inc. stock deliver strong Q4 earnings2025 Market Overview & Long-Term Growth Stock Strategies - newser.com
Is Enliven Therapeutics Inc. stock a contrarian buy2025 Short Interest & Fast Moving Trade Plans - newser.com
Using data filters to optimize entry into Enliven Therapeutics Inc.Oil Prices & Community Supported Trade Ideas - newser.com
Applying sector rotation models to Enliven Therapeutics Inc.Weekly Profit Summary & Daily Risk Controlled Trade Plans - newser.com
Why Enliven Therapeutics Inc. stock appeals to dividend seekers2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Enliven Therapeutics Inc. recovery potential after sell offExit Point & Risk Controlled Swing Alerts - newser.com
Is Enliven Therapeutics Inc. stock a safe haven assetWeekly Earnings Recap & Fast Entry Momentum Alerts - newser.com
Is Enliven Therapeutics Inc. stock cheap compared to fundamentalsInsider Selling & Free Expert Verified Stock Movement Alerts - newser.com
Automated trading signals detected on Enliven Therapeutics Inc.Portfolio Value Report & Safe Swing Trade Setups - newser.com
Is Enliven Therapeutics Inc a good long term investmentFederal Reserve Announcements & Build Wealth With Zero-Cost Tools - earlytimes.in
Enliven Therapeutics (ELVN): Evaluating Valuation Following Phase 1 ELVN-001 Update for Resistant Leukemia - Sahm
Will Enliven Therapeutics Inc. stock outperform tech sector in 2025Quarterly Portfolio Summary & Verified Technical Trade Signals - fcp.pa.gov.br
Enliven Therapeutics Inc (ELVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Enliven Therapeutics Inc 주식 (ELVN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Kintz Samuel | PRESIDENT AND CEO |
Oct 17 '25 |
Sale |
21.33 |
12,500 |
266,654 |
902,892 |
1.02%
0.57%
자본화:
|
볼륨(24시간):